Abiopharma

🔍 Schwab Charles R. (Director)

Company: SCHWAB CHARLES CORP (SCHW)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Sold 46,410 shares of Common Stock at $108.176 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,021,463.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 53,775,791.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by 188 Corp | shares_owned_after: 44,025.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: H | nature_of_ownership: by Spouse as Trustee | shares_owned_after: 10,624,797.33

Footnotes:

• F1: This transaction was executed in multiple trades at prices ranging from $108.02 to $108.35. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.